# Decoy Therapeutics Inc.: Form 8-K, filed Jun 29, 2026

- Company: [Decoy Therapeutics Inc.](/companies/dcoy.md) (CIK 1615219)
- Form: 8-K
- Filed: 2026-06-29
- Accepted by EDGAR: Jun 29, 2026, 06:03 ET
- Period: 2026-06-26
- Accession: 0001193125-26-286737
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/dcoy-20260626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/dcoy-20260626.htm

Filed Jun 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-286737. Last ingested by Listed: Nov 14, 2026, 22:09 ET. No prices; not investment advice.
